Clinical trial
Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions
NCT02432066 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions
- Lead sponsor
- University of Florida
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- September 29, 2018
- Completion date
- December 29, 2020
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.